Schulte-Hermann R, Schuppler J, Timmermann-Trosiener I, Ohde G, Bursch W, Berger H
Environ Health Perspect. 1983 Apr;50:185-94. doi: 10.1289/ehp.8350185.
A number of different compounds, including phenobarbital, hypolipidemic drugs such as clofibrate and nafenopin, the sex steroids progesterone, cyproterone acetate, estradiol and mestranol, chlorinated hydrocarbons such as DDT, hexachlorocyclohexane, and TCDD and the antioxidant butylhydroxytoluene, appears to promote the development of liver tumors from previously induced initiated cells. The mechanisms of tumor promotion by several representative prototypes of these compounds were studied in rat liver in vivo. All liver tumor promoters mentioned above stimulate growth of normal liver. The growth response is due to cellular hypertrophy and/or increased rate of DNA (and cell) replication and/or decreased rate of cell death. Hepatocytes in foci or islands of altered cells (putatively preneoplastic) show higher rates of replication than normal liver cells; various different liver tumor promoters cause a further increase of proliferation of focal cells. The increased proliferative activity is found in different island phenotypes and thus seems to be a useful marker of the putative preneoplastic state. The focal cells respond to several factors limiting proliferation in normal liver, suggesting that they are not autonomous with respect to growth control. Early preneoplastic foci grow slowly without promotion, despite the relatively high rates of cell replication. Thus their cells seem to have a much shorter life-time than normal hepatocytes or to undergo reversion to the normal phenotype. Promoters seem to accelerate island enlargement by increasing cell replication and delaying cell death or remodeling. Thus, tumor promoters enhance the manifestation of the proliferation advantage of the putative initiated cell population. In addition, promoters cause increases in the number of detectable islands. This can partially be explained by enlargement of existing islands, but phenotypic changes that would enhance the probability of detection of remodelling islands and growth of dormant initiated cells, probably contribute to the apparent increase of island number. Putative preneoplastic foci of unknown origin are frequent in the liver of aged Wistar rats. They are morphologically and functionally very similar to those induced by carcinogens and are responsive to the mitogenic effect of tumor promoters. Promotion of these "spontaneous" foci may explain tumor appearance after long-term application of promoters.The findings may provide a basis for improved identification of initiated hepatocytes (and of initiating hepatocarcinogens) and for detection of tumor promoters. All suspected liver tumor promoters tested so far induced enhanced preneoplastic cell proliferation after single doses. The long-term carcinogenicity bioassay as currently performed does not discriminate between initiating and promoting properties of a test compound if the animals used develop spontaneous preneoplastic lesions in the organ affected.
许多不同的化合物,包括苯巴比妥、氯贝丁酯和萘酚平之类的降血脂药物、性类固醇孕酮、醋酸环丙孕酮、雌二醇和炔雌醇甲醚、滴滴涕、六氯环己烷和四氯二苯并二恶英之类的氯代烃以及抗氧化剂丁基羟基甲苯,似乎会促使先前诱导的启动细胞发展为肝肿瘤。在大鼠肝脏中对这些化合物的几种代表性原型的肿瘤促进机制进行了体内研究。上述所有肝肿瘤促进剂均会刺激正常肝脏的生长。生长反应是由于细胞肥大和/或DNA(和细胞)复制速率增加和/或细胞死亡速率降低所致。病灶或细胞改变岛(推测为癌前病变)中的肝细胞显示出比正常肝细胞更高的复制速率;各种不同的肝肿瘤促进剂会导致病灶细胞的增殖进一步增加。在不同的岛状表型中均发现增殖活性增加,因此似乎是推测癌前状态的有用标志物。病灶细胞对限制正常肝脏中增殖的多种因素有反应,这表明它们在生长控制方面并非自主的。尽管细胞复制速率相对较高,但早期癌前病灶在没有促进作用的情况下生长缓慢。因此,它们的细胞似乎比正常肝细胞的寿命短得多,或者会恢复为正常表型。促进剂似乎通过增加细胞复制和延迟细胞死亡或重塑来加速岛的扩大。因此,肿瘤促进剂增强了推测的启动细胞群体增殖优势的表现。此外,促进剂会导致可检测到的岛的数量增加。这部分可以通过现有岛的扩大来解释,但可能会增强重塑岛检测概率和休眠启动细胞生长的表型变化,可能导致岛数量的明显增加。在老年Wistar大鼠的肝脏中,起源不明的推测癌前病灶很常见。它们在形态和功能上与致癌物诱导的病灶非常相似,并且对肿瘤促进剂的促有丝分裂作用有反应。这些“自发”病灶的促进作用可能解释了长期应用促进剂后肿瘤的出现。这些发现可能为改进启动肝细胞(和启动致癌物)的识别以及肿瘤促进剂的检测提供依据。到目前为止,所有测试的可疑肝肿瘤促进剂在单次给药后均诱导了癌前细胞增殖增强。如果所用动物在受影响的器官中出现自发癌前病变,目前进行的长期致癌性生物测定无法区分测试化合物的启动和促进特性。